Amplyx Pharmaceuticals Announces Appointment of CFO and Presentation at the J.P. Morgan 36th Annual Healthcare Conference

Cision PR NewswireRead the rest

APX001: A New Antifungal with Activity Against Candida auris

Contagion LiveRead the rest

Amplyx Pharmaceuticals Highlights Phase 1 APX001 Data at IDWeek 2017

Pipeline ReviewRead the rest

Amplyx Pharmaceuticals Highlights Phase 1 APX001 Data at IDWeek 2017

Cision PR NewswireRead the rest

Amplyx Pharmaceuticals Announces Presentations at IDWeek 2017

Cision PR NewswireRead the rest

Amplyx grows on investors in $67 M Series C

Global Corporate VenturingRead the rest

Fundraising at Two Local Biotechs

San Diego Business Journal OnlineRead the rest

Amplyx Pharmaceuticals Raises $67 Million in Series C Financing

Crossroads TodayRead the rest

Arix Bioscience participates in $67 million Series C financing for Amplyx Pharmaceuticals

Globe NewswireRead the rest

Amplyx Pharmaceuticals Raises $67 Million in Series C Financing

cision PR NewswireRead the rest

Antifungal biotech Amplyx Pharmaceuticals raises $67 million

San Diego Union TribuneRead the rest

New CEO for Amplyx Pharmaceuticals

click hereRead the rest

C-Suite Shuffle at Amplyx Pharmaceuticals

click hereRead the rest

Amplyx Pharmaceuticals Appoints Ciara Kennedy, Ph.D., as President and Chief Executive Officer

click hereRead the rest

FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Multiple Invasive Fungal and Mold Infections

click hereRead the rest

Amplyx Pharmaceuticals Initiates Dosing in Phase 1 Clinical Trial of APX001, a Novel Antifungal Product Candidate for Treatment of Life-Threatening Infections

click hereRead the rest

Amplyx Pharmaceuticals Announces Qualified Infectious Disease Product Designation for APX001 in Three Life-threatening Fungal Infections

click hereRead the rest

Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors

click hereRead the rest

TECH COAST ANGELS FUNDS 31 DEALS IN 2010 AND HIGHLIGHTS THREE PROFITABLE EXITS

IRVINE, Calif., February 22, 2011 Tech Coast Angels (TCA), the nations largest angel investment network, today announced it funded 31 investments, including 12 new deals and 19 follow-on investments in a broad range of start-up businesses, demonstrating its angel investment leadership.… Read the rest

TCA Demonstrates Angel Investment Leadership with 7 New Deals and 17 Follow-On Deals in 2009

TechCoastAngels Demonstrate Angel Investment Leadership with 7 New Deals and 17 Follow-On Deals in 2009

Irvine, Calif.,March 1, 2010– Despite the dire economy and lack of available capital (or maybe because of it), Tech Coast Angels(TCA), the largest angel investmentnetwork in the U.S., completed seven rounds of new investmentdeals and 17 follow-on deals in 2009, raising $4.7 million through direct TCA investments and an additional $57 million through other sources of venture capitaland angel capitalfor the network’s entrepreneurial companies.… Read the rest

Tech Coast Angels Companies Receive More Than $1B

30 TCA Portfolio Companies Secure More Than 75M in 2008

LOS ANGELES – February 23, 2009 – Tech Coast Angels (TCA), the largest angel network in the United States, today announced that more than $1B has been invested in TCA-funded companies since the group’s inception in 1997.
Read the rest